Alumis Inc. Common Stock vs. Johnson & Johnson
Johnson & Johnson (JNJ) comes out ahead, leading on 6 of 8 compared factors.
Size & Scale
| ALMS | JNJ | |
|---|---|---|
| Market Cap | $1.23 billion | $653.54 billion |
| Revenue (TTM) | $7.40 million | $97.93 billion |
| Net Income (TTM) | $-438,957,000 | $21.04 billion |
JNJ leads on 3 of 3 size & scale factors.
Valuation
| ALMS | JNJ | |
|---|---|---|
| P/E Ratio | — | 31.93 |
| Price / Book | 2.71 | 7.69 |
| Price / Sales | 165.69 | 6.67 |
ALMS and JNJ split the valuation factors evenly.
Profitability
| ALMS | JNJ | |
|---|---|---|
| Net Margin | -5933.45% | 21.48% |
| Return on Equity | -97.08% | 24.76% |
JNJ leads on 2 of 2 profitability factors.
Dividend
| ALMS | JNJ | |
|---|---|---|
| Dividend Yield | — | 1.95% |
| Payout Ratio | — | 62.18 |
ALMS and JNJ split the dividend factors evenly.
Risk & Sentiment
| ALMS | JNJ | |
|---|---|---|
| Short Interest | 0.47% | 0.67% |
ALMS leads on 1 of 1 risk & sentiment factors.
Dig deeper: ALMS overview, ALMS financials, JNJ overview, JNJ financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.